Le Lézard
Classified in: Science and technology, Business
Subject: PLW

Topia Awarded New Patent for Machine Learning Models to Identify and Use Seasonality Trend Data


SAN FRANCISCO, Feb. 23, 2023 /PRNewswire/ -- Topia, the world's leading global talent mobility and distributed workforce platform, today announced that it has been awarded a new patent - Apparatus and methods of unsupervised machine learning models to identify seasonality and predicting seasonally-influenced metric values.

With AI and machine learning now being adopted more widely across a wide range of technologies designed for HR, compliance and finance professionals, this patent demonstrates Topia's ongoing commitment to innovation and sets the company up to integrate machine learning models into products and solutions in upcoming releases, wherever it thinks this will provide value for clients.

The patent centers around the use of data related to seasonality. Seasonality is a phenomenon where the values of a certain metric tend to follow a repeating pattern over time. Machine learning models can be used to both identify this seasonality, as well as to predict values for the metric based on the season. This can then be applied in several different ways, such as forecasting demand, predicting prices or anticipating customer or user behavior.

In the context of Topia's solutions, one of many possible applications could be to predict flight rates to help customers better manage the flow of people movement in the business or to manage travel costs more efficiently.

"Our new patent shows that we continue to be at the forefront of technological innovation in the global mobility, travel compliance and distributed workspace," said Shawn Farshchi, CEO at Topia. "With the rise of AI in almost all facets of business life, this patent provides us with the ability to substantially expand Topia's platform with machine learning algorithms across our microservices, and further enhance our workflow automation."

This patent adds to Topia's existing portfolio, demonstrating the company's commitment to delivering fully automated end-to-end Global Talent Mobility.

To learn more about Topia's award-winning solutions, visit www.topia.com

About Topia
Topia is the leader in Global Talent Mobility. We empower companies to deploy, manage and engage employees anywhere in the world. The Topia platform enables organizations to deliver mobility as part of a broader talent strategy encompassing all types of employee movement ? remote and distributed workforces, business travel, and more traditional relocations and assignments. This drives enhanced employee experiences and competitive advantage by ensuring the right people are in the right place at the right time, while staying compliant no matter where they are. The Topia platform automates the entire global talent mobility process, including scenario-based planning, expat payroll, tax and immigration compliance, reporting and more. Topia powers global talent mobility programs for world-renowned brands such as Dell, Veolia, Equinor and AXA. Topia has raised over $100M from NewView Capital (formerly New Enterprise Associates), Notion Capital and others, and is a global company with offices throughout the Americas and EMEA.

MEDIA CONTACT:
Kerri Taranto
Next PR
[email protected]

SOURCE Topia


These press releases may also interest you

at 07:30
Knight Therapeutics Inc. ("Knight"), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2024 financial results on Thursday, May 9, 2024 prior to market opening. Following the release, Knight will hold a...

at 07:30
Quipt Home Medical Corp. (the "Company") ?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, announced today that the Toronto Stock Exchange ("TSX") has accepted the Company's notice of intention to implement a...

at 07:30
Stack Capital Group Inc., ("Stack Capital" or the "Company") today announced its financial results for the quarter ended March 31, 2024. Stack Capital reports all amounts in Canadian Dollars unless otherwise stated. Company Commentary: As at March...

at 07:30
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001 clinical trial show that AB-101 was generally...

at 07:25
Arbutus Biopharma Corporation ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today...

at 07:20
Building on their successful partnership, INVNT GROUP and MSM (Media & Sport Management) enhance service offerings and commercial solutions tailored for talent and brands within the booming motorsports industry.  INVNT GROUP, the global brand...



News published on and distributed by: